Alaunos Therapeutics, Inc.

Biotechnology • Healthcare • Houston, TX, United States • TCRT (NCM)

Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops small molecules to treat obesity and other metabolic disorders. The company develops an oral obesity compound that addresses shortcomings of injectable GLP-1 receptor agonists, including preserving lean muscle mass. It also evaluates ALN1001 and related derivatives on lipid deposition and gene expression. In addition, the company develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is headquartered in Houston, Texas.

346 355 4099 2617 Bissonnet Street, Houston, TX 77005, United States

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

TCRT Stock Surge: What To Expect Next? - StocksToTrade

StocksToTrade • Oct 9

Alaunos Therapeutics And 2 Other Promising Penny Stocks To Watch - Yahoo Finance

Yahoo Finance • Apr 4

Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer - TipRanks

TipRanks • Dec 23

TCRT Stock’s Rollercoaster: What’s Next? - timothysykes.com

timothysykes.com • Oct 9

Alaunos Therapeutics reaches settlement with MD Anderson over unpaid invoices - Investing.com

Investing.com • Dec 23

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has Alaunos Therapeutics, Inc. had layoffs?

No layoff events have been recorded for Alaunos Therapeutics, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does Alaunos Therapeutics, Inc. have?

Alaunos Therapeutics, Inc. has approximately 1 employees.

What industry is Alaunos Therapeutics, Inc. in?

Alaunos Therapeutics, Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is Alaunos Therapeutics, Inc. a publicly traded company?

Yes, Alaunos Therapeutics, Inc. is publicly traded under the ticker symbol TCRT on the NCM. The company has a market capitalization of approximately $0.01 billion.

Where is Alaunos Therapeutics, Inc. headquartered?

Alaunos Therapeutics, Inc. is headquartered in Houston, TX, United States at 2617 Bissonnet Street, Houston, TX 77005, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.